Usana Health Sciences, Inc. (USNA) Tops Q4 EPS by 1c, Offers FY12 Guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $18.90 +0.11%
EPS Growth %: -41.9%
Financial Fact:
Net sales: 254.22M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -41.9%
Financial Fact:
Net sales: 254.22M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Usana Health Sciences, Inc. (NYSE: USNA) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $145.9 million versus the consensus estimate of $144.4 million.
Usana Health Sciences, Inc. sees FY2012 EPS of $3.35-$3.45, versus the consensus of $3.52. Usana Health Sciences, Inc. sees FY2012 revenue of $600-$615 million, versus the consensus of $603.4 million.
For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.
Usana Health Sciences, Inc. sees FY2012 EPS of $3.35-$3.45, versus the consensus of $3.52. Usana Health Sciences, Inc. sees FY2012 revenue of $600-$615 million, versus the consensus of $603.4 million.
For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- Sun Communities names Ileana McAlary as general counsel and EVP
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
